Literature DB >> 16718816

Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.

Hai-Tao Guan1, Xing-Huan Xue, Zhi-Jun Dai, Xi-Jing Wang, Ang Li, Zhao-Yin Qin.   

Abstract

AIM: To investigate the inhibitory effect of small interfering RNA (siRNA) on the expression of survivin in pancreatic cancer cell line PC-2 and the role of siRNA in inducing PC-2 cell apoptosis and enhancing its radiosensitivity.
METHODS: A siRNA plasmid expression vector against survivin was constructed and transfected into PC-2 cells with Lipofectamine 2000. The down regulation of survivin expression was detected by semi-quantitative RT-PCR and immunohistochemical SP method and the role of siRNA in inducing PC-2 cell apoptosis and enhancing its radiosensitivity was detected by flow cytometry.
RESULTS: The sequence-specific siRNA efficiently and specifically down-regulated the expression of survivin at both mRNA and protein levels. The expression inhibition ratio was 81.25% at mRNA level detected by semi-quantitative RT-PCR and 74.24% at protein level detected by immunohistochemical method. Forty-eight hours after transfection,apoptosis was induced in 7.03% cells by siRNA and in 14.58% cells by siRNA combined with radiation.
CONCLUSION: The siRNA plasmid expression vector against survivin can inhibit the expression of survivin in PC-2 cells efficiently and specifically. Inhibiting the expression of survivin can induce apoptosis of PC-2 cells and enhance its radiosensitivity significantly. RNAi against survivin is of potential value in gene therapy of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718816      PMCID: PMC4087808          DOI: 10.3748/wjg.v12.i18.2901

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin.

Authors:  C Chiodino; A M Cesinaro; D Ottani; F Fantini; A Giannetti; G P Trentini; C Pincelli
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

2.  Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.

Authors:  Marzia Pennati; Mara Binda; Michelandrea De Cesare; Graziella Pratesi; Marco Folini; Lorenzo Citti; Maria Grazia Daidone; Franco Zunino; Nadia Zaffaroni
Journal:  Carcinogenesis       Date:  2004-02-04       Impact factor: 4.944

3.  Interactions between double-stranded RNA regulators and the protein kinase DAI.

Authors:  L Manche; S R Green; C Schmedt; M B Mathews
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Survivin expression is a prognostic marker in pancreatic cancer patients.

Authors:  Kazuhiro Kami; Ryuichiro Doi; Masayuki Koizumi; Eiji Toyoda; Tomohiko Mori; Daisuke Ito; Koji Fujimoto; Michihiko Wada; Shin-Ichi Miyatake; Masayuki Imamura
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

Authors:  M A Minks; D K West; S Benvin; C Baglioni
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

7.  Significance of survivin mRNA expression in prognosis of neuroblastoma.

Authors:  Rie Ito; Satoru Asami; Shigeyasu Motohashi; Susumu Ootsuka; Yusuke Yamaguchi; Motoaki Chin; Hiroyuki Shichino; Yukihiro Yoshida; Norimichi Nemoto; Hideo Mugishima; Takashi Suzuki
Journal:  Biol Pharm Bull       Date:  2005-04       Impact factor: 2.233

8.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

Authors:  H Kawasaki; D C Altieri; C D Lu; M Toyoda; T Tenjo; N Tanigawa
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

Authors:  Sílvia Coma; Veronique Noe; Cinzia Lavarino; Jaume Adán; Manuel Rivas; Mariana López-Matas; Roser Pagan; Francesc Mitjans; Senén Vilaró; Jaume Piulats; Carlos J Ciudad
Journal:  Oligonucleotides       Date:  2004

Review 10.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

View more
  22 in total

1.  Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.

Authors:  Jie Wang; Ze Lu; Junfeng Wang; Minjian Cui; Bertrand Z Yeung; David J Cole; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Control Release       Date:  2015-08-10       Impact factor: 9.776

2.  ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.

Authors:  Wen-Sheng Huang; Jian-Ping Wang; Ting Wang; Jie-Yu Fang; Ping Lan; Jin-Ping Ma
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

3.  Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.

Authors:  Wen-Sheng Huang; Tian-Bao Wang; Yao He; Yu-Jun Chen; Shi-Long Zhong; Min Tan
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

4.  Survivin and pancreatic cancer.

Authors:  Bin-Bin Liu; Wei-Hong Wang
Journal:  World J Clin Oncol       Date:  2011-03-10

5.  Experimental study on inhibition of the growth of human adenoid cystic cancer cells by RNA interference targeting against survivingene.

Authors:  Xin Wang; Yu Xiong; Congji Zhang; Jixiang Zhou; Jun Yang; Kun Wang; Xiyan Xia
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.

Authors:  Minjian Cui; Jessie L-S Au; M Guillaume Wientjes; Michael A O'Donnell; Kevin R Loughlin; Ze Lu
Journal:  J Urol       Date:  2015-02-11       Impact factor: 7.450

7.  Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.

Authors:  Jie Wang; Ze Lu; Bertrand Z Yeung; M Guillaume Wientjes; David J Cole; Jessie L-S Au
Journal:  J Control Release       Date:  2014-01-23       Impact factor: 9.776

8.  Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.

Authors:  Kanchan Vishnoi; Sutapa Mahata; Abhishek Tyagi; Arvind Pandey; Gaurav Verma; Mohit Jadli; Tejveer Singh; Sukh Mahendra Singh; Alok C Bharti
Journal:  Tumour Biol       Date:  2016-07-24

9.  Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.

Authors:  Guo-Ying Miao; Qi-Ming Lu; Xiu-Lan Zhang
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

10.  Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.

Authors:  Yi-Liang Bi; Min Min; Wei Shen; Yan Liu
Journal:  Tumour Biol       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.